PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Glycopyrronium bromide - Hypersalivation in children
PAD Profile : Glycopyrronium bromide - Hypersalivation in children
Keywords :
excessive saliva, hypersialosis, drooling, sialorrhoea
Brand Names Include :
Assicco, Sialanar
Traffic Light Status
Status 1 of 3.
Status :
Blue
Important
Formulations :
- Tablets
Important Information :
Licensed in children 3 years and over. Expensive treatment option - consider an alternative. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 3.
Status :
Blue
Important
Formulations :
- Oral solution
Important Information :
1mg/5ml oral solution (sugar free). Licensed in children aged 3 years and over. NOTE - different strengths of liquid are not bioequivalent. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 3 of 3.
Status :
Blue
Important
Formulations :
- Oral solution
Important Information :
Oral solution 320mcg/ml (Sialanar brand). Expressed as 400mcg/ml. Licensed in children 3 years and over. NOTE - different strengths of liquid are not bioequivalent. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
The following guidelines are available for this indication.
Other Drugs
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
04 December 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
01. Gastro-Intestinal System
01.02.00. Antispasmodics and other drugs altering gut motility